GB0515937D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number: GB0515937D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 2005-08-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GB0515937A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

ROS PHARMACEUTICALS Ltd

Original Assignee

ROS PHARMACEUTICALS Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-02

Filing date

2005-08-02

Publication date

2005-09-07

2005-08-02 Application filed by ROS PHARMACEUTICALS Ltd filed Critical ROS PHARMACEUTICALS Ltd

2005-08-02 Priority to GB0515937A priority Critical patent/GB0515937D0/en

2005-09-07 Publication of GB0515937D0 publication Critical patent/GB0515937D0/en

Status Ceased legal-status Critical Current

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
GB0515937A GB0515937D0 (en)	2005-08-02	2005-08-02	Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0515937A GB0515937D0 (en)	2005-08-02	2005-08-02	Pharmaceutical formulation

Publications (1)

Publication Number	Publication Date
GB0515937D0 true GB0515937D0 (en)	2005-09-07

Family

ID=34983988

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB0515937A Ceased GB0515937D0 (en)	2005-08-02	2005-08-02	Pharmaceutical formulation

Country Status (1)

Country	Link
GB (1)	GB0515937D0 (en)

2005
- 2005-08-02 GB GB0515937A patent/GB0515937D0/en not_active Ceased

Similar Documents

Publication	Publication Date	Title
IL185390A (en)	2017-06-29	Solid pharmaceutical dosage formulation
HK1198914A1 (en)	2015-06-19	Novel dosage formulation
AP2008004533A0 (en)	2008-08-31	Pharmaceutical combination
ZA200708705B (en)	2009-12-30	Pharmaceutical composition
GB0614586D0 (en)	2006-08-30	Pharmaceutical Formulation
IL188352A0 (en)	2008-04-13	Pharmaceutical compositions
ZA200804103B (en)	2009-10-28	Pharmaceutical compositions
GB0526419D0 (en)	2006-02-08	Formulation
IL192091A0 (en)	2008-12-29	Pharmaceutical compositions
GB0517673D0 (en)	2005-10-05	Formulation
HK1105358A1 (en)	2008-02-15	Solid pharmaceutical formulation
ZA200804666B (en)	2010-01-27	Pharmaceutical combination
EP1845944A4 (en)	2011-07-27	Pharmaceutical compositions
GB0522045D0 (en)	2005-12-07	Pharmaceutical compositions
GB0501030D0 (en)	2005-02-23	Formulation
EP1864664A4 (en)	2009-02-18	Pharmaceutical preparation
ZA200803566B (en)	2009-10-28	Pharmaceutical compositions
GB0522473D0 (en)	2005-12-14	A pharmaceutical formulation
GB0514259D0 (en)	2005-08-17	Pharmaceutical compositions
GB0515937D0 (en)	2005-09-07	Pharmaceutical formulation
GB0418270D0 (en)	2004-09-15	Pharmaceutical formulation
GB0422111D0 (en)	2004-11-03	Pharmaceutical formulation
GB0500826D0 (en)	2005-02-23	Pharmaceutical use
AU2005903196A0 (en)	2005-06-30	Pharmaceutical formulation
GB0514530D0 (en)	2005-08-24	Pharmaceutical agent

Legal Events

Date	Code	Title	Description
2006-08-30	AT	Applications terminated before publication under section 16(1)